Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development (NCT00243776)
π©Ί Plain-English Summary (8th-Grade Level)
The study team will use small pieces of human hearts which are removed as part of a required surgical procedure to study different objectives. One of the objective is how calcium ions pass through the membrane of heart cells in order to tell the heart cell how much force to contract with when the heart beats. Investigators will also study the proteins and RNA of these pieces to determine how the newborn heart cells control their force of contraction differently from adult heart cells. Investigators hypothesize that infant hearts have different regulation of calcium entry than adult hearts. The study team also wants to study combinations of 3D cardiac spheres with multiple environmental cues that can improve functional and metabolic maturation of Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and generate a more clinically relevant cell model.
Who can join: Review the eligibility criteria below.
Location: Emory University School of Medicine β Atlanta, Georgia
Age range: Not specified to 20 Years
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (1 Sites)
- Emory University School of Medicine β Atlanta, Georgia
π Contact the Study Coordinator
Phone: (404) 727-9858
Email: medavis@emory.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Congenital Heart Disease
- Technical Development for Pediatric Cardiovascular MRI β Washington D.C., District of Columbia
- Harmony TPV Post-Approval Study β Birmingham, Alabama
- The Medtronic Harmonyβ’ Transcatheter Pulmonary Valve Clinical Study β Los Angeles, California
- Autus Valve Pivotal Study β Los Angeles, California
- Peer Coaching Intervention in Young Adults With Congenital Heart Disease β Durham, North Carolina
- SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure β Toronto, Ontario
Explore by condition: All Congenital Heart Disease clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.